Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Sue A. Brown(Diabetes Australia), Roy W. Beck(Jaeb Center for Health Research), Dan Raghinaru(Diabetes Australia), Mei Mei Church(Diabetes Australia), R. Paul Wadwa(Diabetes Australia), Elvira Isganaitis(Joslin Diabetes Center), Vikash Dadlani(Diabetes Australia), Bruce A. Buckingham(Stanford Medicine), Yogish C. Kudva(Diabetes Australia), Gregory P. Forlenza(Diabetes Australia), David W. Lam(Diabetes Australia), Laya Ekhlaspour(Diabetes Australia), Jordan E. Pinsker(Diabetes Australia), Lori M. Laffel(Joslin Diabetes Center), Boris Kovatchev(University of Virginia), Francis J. Doyle(Brown University), Stacey M. Anderson(Diabetes Australia), John W. Lum(Diabetes Australia), Carol J. Levy(Diabetes Australia), Craig Kollman(University of Minnesota), Eyal Dassau(Harvard University)
Cited by 960
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
A rapid DNA isolation procedure for small amounts of fresh leaf tissue
|Medical Entomology and Zoology|1987|2.4k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
|New England Journal of Medicine|1992|1.3k
Dynamic Flux Balance Analysis of Diauxic Growth in Escherichia coli
|Biophysical Journal|2002|962